SHANGHAI/LONDON (Reuters) - GlaxoSmithKline said on Monday it was investigating new allegations that its staff had used improper tactics to market Botox in China, but had so far found no evidence of bribery or corruption. The move follows a claim that GSK staff allegedly handed doctors cash and other rewards for prescribing Botox treatment, which the British group sells in China under an agreement with patent-holder Allergan. ...
Courtesy of Yahoo News
See Also
http://wiki.fachschaftsrat.info/index.php?title=Are_You_Searching_Frantically_For_Helpful_Advice_On_Slimming_Pills
http://www.43things.com/entries/view/5967172
http://www.afrocubanos.net/blogs/viewstory/434
http://wiki.montanaecosmart.com/wiki/The_Benefits_Of_Weight_Loss_Supplements
http://wuluri.soup.io/post/314742118/Effective-Weight-Loss-Tips
http://my.mors.by/blogs/7931/18502/the-actual-facts-concerning-effe
No comments:
Post a Comment